JCI table of contents December, 2005

November 10, 2005

CARDIOLOGY

Arrhythmias: how the mitochondria can break the heart

In a paper appearing online on November 10 in advance of print publication of the December issue of the Journal of Clinical Investigation, Brian O'Rourke and colleagues from Johns Hopkins University describe how failure of the mitochondrial network at the muscle-cell level leads to differential electrical excitability in hearts subjected to ischemia and reperfusion.

This work introduces a new mechanism to explain post-ischemic arrhythmias, in which disturbed mitochondrial function in clusters of cells in the reperfused heart leads to regional current sinks that prevent propagation.

The authors show that stabilizing mitochondrial membrane potential stabilizes the cellular action potential (AP), blunts AP shortening during ischemia, and prevents ventricular arrhythmias during reperfusion. This work could explain ischemia-related arrhythmias and explores the therapeutic potential of a compound targeting the mitochondria.

TITLE: The mitochondrial origin of post-ischemic arrhythmias

AUTHOR CONTACT:
Brian O'Rourke
Johns Hopkins University, Baltimore, MD USA
Phone: 410-614-0034
Fax: 410-955-7953
E-mail: bor@jhmi.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=25371

METABOLIC DISEASE

Reversing obesity and diabetes works when leptin signaling is on the brain

Leptin is a hormone derived from fat cells, and defects in leptin signaling leads to obesity, overeating, and decreased energy output. Leptin signals through the leptin receptor, LEPR.

In a paper appearing online on November 10 in advance of print publication of the December issue of the Journal of Clinical Investigation, Streamson Chua and colleagues use transgenic mice to show that only one isoform of leptin receptor, LEPR-B, expressed exclusively in neurons, is sufficient to produce normal body composition and normal body weight. Brain specific leptin signaling was sufficient to reverse the obesity, diabetes, and infertility seen in db/db mice, which carry a defective leptin receptor.

This data provides evidence that leptin's effects on body composition, insulin sensitivity, and fertility are mediated by the nervous system and that the extraneural effects of leptin, with regard to body composition and insulin sensitivity, may be limited.

TITLE: Complete rescue of obesity/diabetes and infertility in db/db mice with neuron-specific LEPR-B transgenes

AUTHOR CONTACT:
Streamson C. Chua, Jr.
Albert Einstein College of Medicine, New York, NY USA
Phone: 718-431-2986
Fax: 718-430-8557
E-mail: streamson@gmail.com

View the PDF of this article at: https://www.the-jci.org/article.php?id=24059

IMMUNOLOGY

New target in autoimmune skin blistering disease pops up

For decades, intravenous Ig has been used to treat a variety of immune and inflammatory diseases and numerous mechanisms have been proposed to explain its mode of action. Studies using animal models of autoimmune skin blistering diseases suggested that intravenous Ig protects against these autoimmune diseases as well.

In a paper appearing online on November 10 in advance of print publication of the December issue of the Journal of Clinical Investigation, Zhi Liu and colleagues from the University of North Carolina demonstrate a common mechanism for intravenous Ig activity in three autoimmune blistering disease models, which have distinct disease pathology - bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV). The authors show that intravenous Ig accelerates the degradation of pathogenic autoantibodies and prevents blistering. It does this by saturating the Fc receptor, FcRn.

The results give new insights into the pathology of these types of diseases and suggest that FcRn is a promising therapeutic target for treating such IgG-mediated autoimmune diseases.

TITLE: Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

AUTHOR CONTACT:
Zhi Liu
University of North Carolina Chapel Hill, NC USA
Phone: 919-966-0785
Fax: 919-966-3898
E-mail: zhiliu@med.unc.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=24394

IMMUNOLOGY

Coughing up a new player in emphysema

The cytokine IFN-gamma helps regulate the immune response. Dysregulated IFN-gamma is associated with many diseases where inflammation and remodeling take place, including atherosclerosis, rheumatoid arthritis, and pulmonary emphysema. However, the mechanism whereby IFN-gamma mediates these tissue changes has not been clear.

In a paper appearing online on November 10 in advance of print publication of the December issue of the Journal of Clinical Investigation, Jack Elias and colleagues from Yale University show that that a receptor called CCR5 plays a key role in the pathogenesis of IFN-gamma-induced and cigarette smoke-induced inflammation, tissue remodeling and emphysema.

Using mouse models, the authors demonstrate that IFN-gamma is a potent stimulator of a variety of chemokines - chemical mediators produced in inflammation that mobilize and activate white blood cells. Inactivating CCR5 decreases IFN-gamma-induced inflammation.

Further, the authors show that emphysema due to cigarette smoke exposure occurs via IFN-gamma-dependent mechanisms and this response is decreased in mice lacking CCR5. These studies highlight the importance of CCR5 in the pathogenesis of IFN-gamma-induced and cigarette smoke-induced changes in lung tissue.

TITLE: Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema

AUTHOR CONTACT:
Jack A. Elias
Yale University School of Medicine, New Haven, CT USA
Phone: 203-785-4163
Fax: 203-785-3826
E-mail: jack.elias@yale.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=24858
-end-


JCI Journals

Related Leptin Articles from Brightsurf:

The leptin activator: New study reveals brain receptor key to burning brown fat
In a new study published in Nature Communications, Michigan researchers reveal a pathway by which the hormone leptin contributes to weight loss.

Researchers find new mutation in the leptin gene
Texas Biomed Staff Scientist Raul Bastarrachea, M.D., is part of a team that discovered a new mutation in the gene that regulates the key hormone suppressing hunger called leptin.

Yale-led study reveals biology of leptin, the hunger hormone
In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity.

How celastrol sensitizes brains to leptin, curbing hunger and obesity
Celastrol's potent anti-obesity effects were widely reported in 2015. Derived from the roots of the thunder god vine, the drug curbed food intake in obese mice by nearly 80 percent, producing up to a 45 percent weight loss.

Leptin's neural circuit identified
Scientists identified a neural circuit in the hypothalamus as the primary mechanism mediating the hormone leptin's anti-obesity and anti-diabetes effects and found two mechanisms underlying leptin's inhibition of appetite.

Obese inducing brain mechanism
The research group of Professor Masaharu Noda, Associate Professor Takafumi Shintani, and a graduate student Satoru Higashi of the National Institute for Basic Biology (NIBB) demonstrated that protein tyrosine phosphatase receptor type J (PTPRJ) inhibits leptin signaling and that induction of PTPRJ in the hypothalamus is a cause of leptin resistance.

Study: Liver responds positively to leptin treatment in patients with lipodystrophy
Researchers at Michigan Medicine have found the livers of patients with a rare disease that affects metabolism have responded positively to leptin therapy.

Researchers come up with new answers concerning a weight-regulating hormone
For years, scientists have failed to locate the DNA variants that control the weight-regulating hormone, leptin.

Satiety hormone leptin plays a direct role in cardiovascular disease in obesity
While high levels of the satiety hormone leptin don't help obese individuals lose weight, they do appear to directly contribute to their cardiovascular disease, researchers report.

Body fat hormone leptin influences runner's high
The euphoric feeling that gives runners a motivational boost in the middle of their workout is in part modulated by the satiety hormone leptin, says new Cell Metabolism study.

Read More: Leptin News and Leptin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.